Page last updated: 2024-11-04

terazosin and Substance Withdrawal Syndrome

terazosin has been researched along with Substance Withdrawal Syndrome in 1 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
"The effect of withdrawal of terazosin therapy in patients with mild to moderate hypertension was assessed in two double-blind, placebo-controlled studies."9.06Effect of withdrawal of terazosin therapy in patients with hypertension. ( Ruoff, G, 1986)
"The effect of withdrawal of terazosin therapy in patients with mild to moderate hypertension was assessed in two double-blind, placebo-controlled studies."5.06Effect of withdrawal of terazosin therapy in patients with hypertension. ( Ruoff, G, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruoff, G1

Trials

1 trial available for terazosin and Substance Withdrawal Syndrome

ArticleYear
Effect of withdrawal of terazosin therapy in patients with hypertension.
    The American journal of medicine, 1986, May-23, Volume: 80, Issue:5B

    Topics: Adrenergic alpha-Antagonists; Blood Pressure; Clinical Trials as Topic; Dizziness; Female; Follow-Up

1986